Hims & Hers Health, Inc. (HIMS)
NYSE: HIMS · Real-Time Price · USD
29.32
+1.33 (4.75%)
At close: Sep 21, 2026, 4:00 PM EDT
29.35
+0.03 (0.10%)
After-hours: Sep 21, 2026, 4:01 PM EDT

Hims & Hers Health Income Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Quarter
Q2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024Q2 2024Q1 2024Q4 2023Q3 2023Q2 2023Q1 2023Q4 2022Q3 2022Q2 2022Q1 2022Q4 2021Q3 2021
Period Ending
Jun '26 Mar '26 Dec '25 Sep '25 Jun '25 Mar '25 Dec '24 Sep '24 Jun '24 Mar '24 Dec '23 Sep '23 Jun '23 Mar '23 Dec '22 Sep '22 Jun '22 Mar '22 Dec '21 Sep '21
753.21608.1617.82598.98544.83586.01481.14401.56315.65278.17246.62226.7207.91190.77167.2144.84113.56101.3184.774.17
Revenue Growth (YoY)
38.25%3.77%28.41%49.16%72.61%110.66%95.09%77.13%51.82%45.81%47.50%56.52%83.08%88.30%97.41%95.27%87.11%93.66%104.26%79.49%
Cost of Revenue
272.41182.82173.38156.92128.64155.32111.683.6759.0449.0842.5639.3937.7537.3534.8730.3826.3926.5622.619.3
Gross Profit
480.8425.29444.44442.06416.2430.69369.54317.89256.61229.1204.06187.31170.16153.43132.34114.4587.1874.7662.154.87
Selling, General & Admin
521.95426.37386.64389.67351.63342.88324.62274.42226.93203.87188.04183.59167.59153.51134.44125.33100.5185.5969.8776.29
Research & Development
54.946.9440.9640.5837.8529.9123.7521.0918.6215.2513.4112.2711.810.758.317.986.866.095.576.24
Operating Expenses
576.85473.31427.61430.25389.47372.79348.37295.51245.54219.12201.44195.86179.39164.26142.75133.31107.3791.6875.4482.53
Operating Income
-96.04-48.0216.8311.8126.7257.921.1822.3711.079.982.62-8.55-9.24-10.83-10.41-18.86-20.19-16.92-13.34-27.66
Interest Expense
-3.75-2.87-1.5-1.6-1.08-0.1--------------
Interest & Investment Income
67.96.818.017.22.72.742.642.4-2.62.342.171.911.470.610.360.180.090.1
Other Non Operating Income (Expenses)
-2.43-18.58-0.58-5.990.0100.95-1.42-0.012.5-0.01-0.7-0.11-0.33-0.90.520.170.59-9.938.44
EBT Excluding Unusual Items
-96.22-61.5721.5612.2232.8560.524.8723.5913.4612.485.21-6.92-7.17-9.25-9.84-17.73-19.67-16.16-23.18-19.11
Merger & Restructuring Charges
--30.37.9---1.4------------8.07-
Gain (Loss) on Sale of Investments
4.74-9.684.44-----------------
Asset Writedown
-1.15--------0.04-0.08----0.43--1.13----
Other Unusual Items
---15.54----3.98----3.02----1.19-----
Pretax Income
-92.63-101.5518.3512.2232.8560.522.2923.5913.4212.42.2-6.92-7.17-9.68-11.03-18.86-19.67-16.16-31.25-19.11
Income Tax Expense
-6.34-9.44-2.25-3.55-9.6511.01-3.73-520.131.280.950.65-0.010.39-0.12-0.020.010.09-0.09-3.17
Net Income
-86.29-92.1220.615.7742.5149.4926.0375.5913.311.131.25-7.57-7.16-10.07-10.91-18.84-19.68-16.25-31.16-15.94
Net Income to Common
-86.29-92.1220.615.7742.5149.4926.0375.5913.311.131.25-7.57-7.16-10.07-10.91-18.84-19.68-16.25-31.16-15.94
Net Income Growth (YoY)
---20.84%-79.13%219.66%344.69%1990.36%-------------
Shares Outstanding (Basic)
232228227226224222219217215213212210208207206205204203201200
Shares Outstanding (Diluted)
232228248249257247241235235229222210208207206205204203201200
Shares Change (YoY)
-9.75%-7.40%3.06%5.79%9.37%7.52%8.51%11.87%12.65%10.73%7.62%2.39%2.19%2.19%2.37%2.60%6.27%32.41%153.89%461.68%
EPS (Basic)
-0.37-0.400.090.070.190.220.120.350.060.050.01-0.04-0.03-0.05-0.05-0.09-0.10-0.08-0.15-0.08
EPS (Diluted)
-0.37-0.400.090.060.170.200.110.320.060.050.01-0.04-0.03-0.05-0.05-0.09-0.10-0.08-0.15-0.08
EPS Growth (YoY)
---17.38%-80.27%197.86%313.60%1826.75%-------------

Additional Metrics

Fiscal Quarter
Q2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024Q2 2024Q1 2024Q4 2023Q3 2023Q2 2023Q1 2023Q4 2022Q3 2022Q2 2022Q1 2022Q4 2021Q3 2021
Period Ending
Jun '26 Mar '26 Dec '25 Sep '25 Jun '25 Mar '25 Dec '24 Sep '24 Jun '24 Mar '24 Dec '23 Sep '23 Jun '23 Mar '23 Dec '22 Sep '22 Jun '22 Mar '22 Dec '21 Sep '21
Free Cash Flow
-61.8759.511.9283.46-65.1853.7661.8781.9350.3815.2613.3521.9112.158.85-8.124.95-6.57-19.5-3.66-16.12
Free Cash Flow Per Share
-0.270.260.010.34-0.250.220.260.350.210.070.060.100.060.04-0.040.02-0.03-0.10-0.02-0.08
Gross Margin
63.83%69.94%71.94%73.80%76.39%73.50%76.81%79.16%81.30%82.36%82.74%82.62%81.84%80.42%79.15%79.02%76.76%73.79%73.32%73.98%
Operating Margin
-12.75%-7.90%2.72%1.97%4.91%9.88%4.40%5.57%3.51%3.59%1.06%-3.77%-4.44%-5.68%-6.23%-13.02%-17.78%-16.70%-15.75%-37.29%
Profit Margin
-11.46%-15.15%3.33%2.63%7.80%8.44%5.41%18.82%4.21%4.00%0.51%-3.34%-3.44%-5.28%-6.52%-13.01%-17.33%-16.04%-36.79%-21.49%
Free Cash Flow Margin
-8.21%9.79%0.31%13.93%-11.96%9.17%12.86%20.40%15.96%5.49%5.41%9.67%5.84%4.64%-4.86%3.42%-5.79%-19.25%-4.32%-21.73%
EBITDA
-66.57-26.0734.9229.4837.1966.1727.2426.7614.7112.985.27-6.19-6.86-8.72-8.4-16.95-18.37-15.18-11.71-26.12
EBITDA Margin
-8.84%-4.29%5.65%4.92%6.83%11.29%5.66%6.66%4.66%4.67%2.14%-2.73%-3.30%-4.57%-5.03%-11.71%-16.18%-14.98%-13.83%-35.21%
D&A For EBITDA
29.4821.9518.0917.6710.478.286.064.383.6432.662.362.382.122.011.91.821.741.631.55
EBIT
-96.04-48.0216.8311.8126.7257.921.1822.3711.079.982.62-8.55-9.24-10.83-10.41-18.86-20.19-16.92-13.34-27.66
EBIT Margin
-12.75%-7.90%2.72%1.97%4.91%9.88%4.40%5.57%3.51%3.59%1.06%-3.77%-4.44%-5.68%-6.23%-13.02%-17.78%-16.70%-15.75%-37.29%
Effective Tax Rate
-----18.20%--0.95%10.28%43.31%---------
SEC Filings: 10-K · 10-Q